Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “IgG4-related Sclerosing Cholangitis”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Early research (Phase 1)Study completedNCT02705638
What this trial is testing

Treatment of IgG4-Related Disease With Revlimid and Rituximab

Who this might be right for
Immunoglobulin G Subclass 4 Related DiseaseIgG4-related DiseaseAutoimmune Pancreatitis+2 more
Mayo Clinic 6
Not applicableStudy completedNCT02616705
What this trial is testing

Bile Usefulness for Detecting IgG4-related Sclerosing Cholangitis

Who this might be right for
IgG4-related Sclerosing CholangitisIgG4-related Disease
Mayo Clinic 511
Not applicableUnknownNCT05463445
What this trial is testing

Multicenter Observational Study of PSC and IgG4-SC in China

Who this might be right for
Primary Sclerosing CholangitisIgG4-related Sclerosing Cholangitis
RenJi Hospital 1,000
Not applicableUnknownNCT02797665
What this trial is testing

Treatment of Obstructive Jaundice in Autoimmune Pancreatitis and/or Immunoglobulin G4-related Sclerosing Cholangitis by Corticosteroids

Who this might be right for
Autoimmune PancreatitisIgG4-related Sclerosing CholangitisObstructive Jaundice
Peking Union Medical College Hospital 30
Testing effectiveness (Phase 2)Study completedNCT01584388
What this trial is testing

Rituximab in IgG4-RD: A Phase 1-2 Trial

Who this might be right for
Retroperitoneal FibrosisAutoimmune PancreatitisSialadenitis+1 more
Massachusetts General Hospital 30
Post-approval studies (Phase 4)Study completedNCT02703194
What this trial is testing

Leflunomide for Maintenance of Remission in IgG4 Related Disease

Who this might be right for
Immunoglobulin G4 Related Sclerosing Disease
Chinese PLA General Hospital 68